Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Antidilutive Potential Shares of Common Stock (Details) - shares	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Schedule of Antidilutive Potential Shares of Common Stock and Net Loss Per Share [Line Items]
Total anti-dilutive shares excluded	159,477,800	509,365
Series A convertible preferred shares [Member]
Schedule of Antidilutive Potential Shares of Common Stock and Net Loss Per Share [Line Items]
Total anti-dilutive shares excluded	149,540,340
Stock options [Member]
Schedule of Antidilutive Potential Shares of Common Stock and Net Loss Per Share [Line Items]
Total anti-dilutive shares excluded	512,620	213,693
Warrants [Member]
Schedule of Antidilutive Potential Shares of Common Stock and Net Loss Per Share [Line Items]
Total anti-dilutive shares excluded	1,116,913
Convertible notes [Member]
Schedule of Antidilutive Potential Shares of Common Stock and Net Loss Per Share [Line Items]
Total anti-dilutive shares excluded	8,307,927	295,672